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Value of supplemental interventions to enhance the effectiveness
of physical exercise during respiratory rehabilitation in COPD
patients. A systematic review
Abstract
BACKGROUND: There is a controversy about the additional benefit of various supplemental
interventions used in clinical practice to further enhance the effectiveness of respiratory rehabilitation in
patients with Chronic obstructive pulmonary disease (COPD). The aim of this research was to assess
randomised controlled trials (RCTs) testing the additional benefit of supplemental interventions during
respiratory rehabilitation in COPD patients. METHODS: Systematic review with literature searches in
six electronic databases, extensive hand-searching and contacting of authors. Two reviewers selected
independently eligible RCTs, rated the methodological quality and extracted the data, which were
analyzed considering the minimal important difference of patient-important outcomes where possible.
FINDINGS: We identified 20 RCTs whereof 18 provided sufficient data for analysis. The
methodological quality was low and sample sizes were too small for most trials to produce meaningful
results (median total sample size = 28). Data from five trials showed that supplemental oxygen during
exercise did not have clinically meaningful effects on health-related quality of life while improvements
of exercise capacity may be even larger for patients exercising on room air. RCTs of adding assisted
ventilation, nutritional supplements or a number of anabolically acting drugs do not provide sufficient
evidence for or against the use any of these supplemental interventions. INTERPRETATION: There is
insufficient evidence for most supplemental interventions during respiratory rehabilitation to estimate
their additional value, partly due to methodological shortcomings of included RCTs. Current data do not
suggest benefit from supplemental oxygen during exercise, although the methodological quality of
included trials limits conclusions. To appropriately assess any of the various supplemental interventions
used in clinical practice, pragmatic trials on respiratory rehabilitation of COPD patients need to consider
methodological aspects as well as appropriate sample sizes.
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Abstract
Background: There is a controversy about the additional benefit of various supplemental interventions
used in clinical practice to further enhance the effectiveness of respiratory rehabilitation in patients with
Chronic obstructive pulmonary disease (COPD). The aim of this research was to assess randomised
controlled trials (RCTs) testing the additional benefit of supplemental interventions during respiratory
rehabilitation in COPD patients.
Methods: Systematic review with literature searches in six electronic databases, extensive hand-searching
and contacting of authors. Two reviewers selected independently eligible RCTs, rated the methodological
quality and extracted the data, which were analyzed considering the minimal important difference of
patient-important outcomes where possible.
Findings: We identified 20 RCTs whereof 18 provided sufficient data for analysis. The methodological
quality was low and sample sizes were too small for most trials to produce meaningful results (median total
sample size = 28). Data from five trials showed that supplemental oxygen during exercise did not have
clinically meaningful effects on health-related quality of life while improvements of exercise capacity may
be even larger for patients exercising on room air. RCTs of adding assisted ventilation, nutritional
supplements or a number of anabolically acting drugs do not provide sufficient evidence for or against the
use any of these supplemental interventions.
Interpretation: There is insufficient evidence for most supplemental interventions during respiratory
rehabilitation to estimate their additional value, partly due to methodological shortcomings of included
RCTs. Current data do not suggest benefit from supplemental oxygen during exercise, although the
methodological quality of included trials limits conclusions. To appropriately assess any of the various
supplemental interventions used in clinical practice, pragmatic trials on respiratory rehabilitation of COPD
patients need to consider methodological aspects as well as appropriate sample sizes.
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Chronic obstructive pulmonary disease (COPD) has a
large impact on health-related quality of life (HRQL) and
represents a major health burden in industrialized and
developing countries [1-4]. A systematic review including
23 randomized controlled trials (RCTs) has shown that
patients with COPD improve their HRQL and exercise
capacity during respiratory rehabilitation[5]. Recent data
on long-term outcomes after respiratory rehabilitation
show reductions of exacerbations and hospitalizations [6-
8].
Physical exercise is the central component of respiratory
rehabilitation programs because it reverses peripheral
muscle dysfunction[9], a highly prevalent comorbidity of
COPD associated with increased risk of exacerbations and
mortality[10,11]. While respiratory rehabilitation includ-
ing physical exercise has become a cornerstone of COPD
management [12-14], there is controversy about the addi-
tional value of several supplemental interventions to sup-
port exercise programs such as oxygen during exercise[15]
or anabolically acting hormones[16].
Clinicians, who consider these supplemental interven-
tions during respiratory rehabilitation programs, should
know their benefits and downsides. They need evidence
from RCTs directly comparing respiratory rehabilitation
with or without supplements in order to carefully discuss
these benefits and downsides with their patients. There-
fore, we conducted a systematic review of pragmatic RCTs
comparing the effects respiratory rehabilitation with and
without any supplemental intervention to assess their
added value in HRQL and exercise capacity improvement.
Methods
Identification of studies
We performed electronic database searches in MEDLINE
(Ovid version, New York, New York, from inception to
May 2004), EMBASE (DataStar version, Cary, North Caro-
lina from inception to December 2003), PEDRO (online
version, University of Sydney, Australia, December 2003)
and the Cochrane Central Register of Controlled Trials
(Oxford, United Kingdom, 2003, Issue 4). We also
searched the Science Citation Index database (Web of Sci-
ence, Thomson ISI, Philadelphia, Pennsylvania) and the
"related articles" function of PubMed (National Library of
Medicine, Washington, Maryland) by entering all
included studies. In addition, we hand searched the bibli-
ographies of all included studies, of reviews on respiratory
rehabilitation or physical exercise in patients with COPD
that were identified in the literature search, as well as the
Proceedings of the International Conferences of the Amer-
ican Thoracic Society and the congress of the European
Respiratory Society to identify further relevant studies. We
also contacted authors in the field to ask for published or
unpublished data.
Selection criteria
We included RCTs investigating any supplemental inter-
vention added to respiratory rehabilitation that included
a standardized physical exercise program. We focused on
standardized exercise programs because only these allow
reproduction in clinical practice. A standardized exercise
protocol was defined as the use of an identical exercise
activity for all patients (e.g. treadmill walking or cycle
ergometer training) at measurable exercise intensity (e.g.
in Watts, metabolic equivalents or kilograms). We
included studies if more than 90% of study participants
patients had COPD according to the following criteria: (1)
a clinical diagnosis of COPD, (2) irreversible airways
obstruction and (3) one of the following: (a) best
recorded FEV1/FVC ratio of individual patients < 0.7; (b)
best recorded FEV1 of individual patients < 70% of pre-
dicted value. We considered the following outcome meas-
ures: HRQL as measured by generic (e.g. SF-36) or disease-
specific (e.g. St. George Respiratory Questionnaire) ques-
tionnaires, symptom scales, functional exercise capacity as
measured walk tests and results from cardiopulmonary
exercise testing. We did not apply any language
restrictions.
We excluded studies that compared any exercise program
versus usual care (i.e. no exercise) or studies that used
unstandardised exercise protocols (e.g. home exercise
programs).
Data extraction and quality assessment
The bibliographic details of all retrieved articles were
stored in a Reference Manager file. We removed duplicate
records resulting from the various database searches. Two
members of the review team independently scrutinized
the titles and abstracts of all identified citations (see figure
1). We ordered the full text of any article that was deemed
potentially eligible by one of the reviewers. The two
reviewers then evaluated the full text of all retrieved
papers, made a decision on in- or exclusion and discussed
the decisions. Any disagreement was resolved by consen-
sus with close attention to the inclusion and exclusion cri-
teria. Final decisions on papers were recorded in the
Reference Manager file and bibliographic details as well as
the reasons for exclusion. We recorded the initial degree of
agreement between the reviewers and corrected discord-
ant scores based on obvious errors. We resolved discord-
ant scores based on real differences in interpretation
through consensus.
Details about study patients, interventions and outcome
measures as well as the results were extracted onto aPage 2 of 11
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five studies with high likelihood for inclusion.
Two reviewers independently evaluated the methodologi-
cal quality of included trials reported in full reports using
a detailed list of quality items assessing components of
internal validity[17] (table 3, see Additional file 3). We
also contacted the authors of the primary studies to obtain
missing information.
Data synthesis and interpretation
We summarized the results of the data extraction and
assessment of study validity in structured tables to allow
looking at the variation in patient characteristics, inter-
ventions, outcome measures, study quality and results. In
addition, we used forest plots to compare results across
the trials. If appropriate we planned to explore sources of
heterogeneity (i.e. differences between studies) using
multivariable regression models (study level meta-regres-
sion analysis) where clinical and methodological items
would act as explanatory variables. No pooling was
undertaken in the presence of significant source
heterogeneity.
Whenever possible, for each outcome, estimates and con-
fidence limits was related to its minimal important differ-
ence[18]. We assessed whether the estimates and 95%
confidence limits for the difference between study groups
exceeded the minimal important difference (for the Six-
minute walk distance ± 50 meters[19], Chronic Respira-
tory Questionnaire ± 0.5 points[20] and St. George Respi-
ratory Questionnaire ± 4 points)[21].
Data were analyzed using STATA (version 8.2, Stata Corp.,
College Station, Texas).
Results
Study selection
Figure 1 shows the study selection process and agreement
on study inclusion. Main reasons for study exclusion
(Appendix, see Additional file 6) were that patients did
not have an exercise programme but only exercise testing
with or without oxygen (n = 12), studies were not RCTs (n
= 8) and that the control group had no exercise pro-
gramme (n = 5). We excluded only one study because of
an undefined exercise programme. We excluded two tri-
als[22,23] from the analysis because the abstract provided
little information and the authors did not provide further
details. Initially, we excluded another abstract, but since
this trial was published in the meantime[24], we could
include it in the analysis.
Quality assessment
Table 3 (see Additional file 3) shows a detailed assessment
of the methodological quality of the included trials. Inter-
rater agreement for all items of the quality assessment was
87% (chance corrected agreement: κ = 0.76). In general,
most included trials scored poorly on the checklist used.
Important methodological aspects that bear on the valid-
ity such as blinding of outcome assessors were not or just
partially addressed in most trials.
Supplemental oxygen during exercise
The characteristics of the five trials on supplemental oxy-
gen [25-29] are summarized in table 1 (see Additional file
1) and the results shown in figures 2 and 3. There was a
trend towards larger improvements of HRQL and exercise
duration in constant work rate tests in the groups with
oxygen, but patients exercising on room air had larger
Study flow from identification to final inclusion of studiesFigure 1
Study flow from identification to final inclusion of studies.
Excluded after full text assessment (see also 
appendix)
Reasons for exclusion: 
- Only exercise testing, no
  Exercise programme n=12
- No RCT n=8
- Control group without exercise n=5 
- Unstandardised exercise program n=1 
- Other reasons n=2 
Total: n=28
Citations excluded after screening titles and 
abstracts
n=1474
Studies retrieved for detailed evaluation:
- From electronic databases: n=29
- From hand searching (conference proceedings, reference lists 
of reviews and identified studies, Science Citation Index and 
“related articles” function of PubMed entering identified studies):
n=19
Total: n=48 
All studies identified n=20 
From electronic databases n=13 
From hand searching n=7
Studies providing enough data n=18*
Exercise ± oxygen n=5 
Exercise ± assisted ventilation n=4 
Exercise ± anabolic steroids n=2 
Exercise ± nutrition n=2 
Exercise ± growth hormone n=2 
Exercise ± tiotropium n=1 
Exercise ± creatine n=1 
Exercise ± ubidecarenone n=1 
* Schols 1995 counted twice for anabolic steroids and nutrition.
For study details, see tables 1 and 2.
Total citations identified from electronic databases (Medline, 
Embase, Pedro, CENTRAL) 
n=1503
Initial agreement on 
in- and exclusion: 
87%, N=0.76Page 3 of 11
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reported that the use of oxygen enabled patients to exer-
cise at higher intensity (mean 62 Watt [SD 19] corre-
sponding to 138% of baseline maximum exercise
capacity) compared with patients on room air (52 Watt
[SD 22] corresponding to 96% of baseline maximum
exercise capacity, p < 0.01 for difference between groups).
In the trial by Rooyackers[28], patients achieved mean
exercise intensities corresponding to 124% of maximum
exercise capacity in the group with oxygen and 114% of
maximum exercise capacity in the group without oxygen
(p = 0.12). Two trials reported on safety of exercise with
oxygen or room air. Rooyackers[28] assessed whether oxy-
gen prevented the development of pulmonary hyperten-
sion. The investigators did not find any differences
between groups in resting mean pulmonary artery pres-
sure measured by Doppler echocardiography. Wad-
dell[29] did not find significant CO2 retention during
walking tests despite high oxygen flow of 5 l/minute.
Assisted ventilation
Two trials[30,31] evaluated proportional assist ventila-
tion during exercise and did not find an additional benefit
(tables 1 and 4, see Additional files 1 and 4). Only
50%[30] and 71.4%[31] of patients exercising with posi-
tive pressure ventilation and 67%[30] and 60%[31] exer-
cising without positive pressure ventilation completed
these trials.
Garrod[32] assessed the benefit of overnight non-invasive
positive pressure ventilation at home during the training
period. They found a statistically significant improvement
of the walking distance for patients assigned to overnight
non-invasive positive pressure ventilation. HRQL
improvements also tended to be larger for patients with
ventilation, but the difference reached only statistical sig-
nificance for the fatigue domain and total score of the
CRQ.
Effect of supplemental oxygen on health-related quality of lifeFigure 2
Effect of supplemental oxygen on health-related quality of life. The forest plot shows the results from three trials 
comparing physical exercise with and without oxygen, separately for each domains of the Chronic Respiratory Questionnaire 
(CRQ). The x-axis represents the difference in change scores between study groups with negative values favoring exercise on 
room air and positive values favoring exercise with supplemental oxygen. A difference of 0 means that both study groups 
changed to the same amount. Boxes with 95% confidence intervals represent point estimates for the difference between the 
CRQ change scores (from baseline to follow-up) of the study groups. Dotted lines represent the minimal important difference 
of the CRQ (change of 0.5). On the right of the forest plot, point estimates for differences between groups and 95% confidence 
intervals are shown.
Differences (95% CI)
-0.20 (-0.92 to 0.52)
0.34 (-0.21 to 0.88)
0.00 (-0.66 to 0.66)
0.18 (-0.46 to 0.81) 
0.23 (-0.63 to 1.09)
0.25 (-0.48 to 0.98)
0.37 (-0.18 to 0.93)
0.25 (-0.45 to 0.95)
0.29 (-0.31 to 0.88)
0.43 (-0.23 to 1.08)
0.07 (-0.53 to 0.66)
0.25 (-0.58 to 1.08)
CRQ domain
Dyspnoea
Study (n oxygen/room air)
Fatigue
Emotional 
Function
Mastery Rooyackers 1997 (12/12)
Garrod 2000 (13/12)
Emtner 2003 (14/15)
Difference between 
CRQ change scores
Favors room air Favors oxygen
-1 -.75 -.5 -.25 0 .25 .5 .75 1
Rooyackers 1997 (12/12)
Garrod 2000 (13/12)
Emtner 2003 (14/15)
Rooyackers 1997 (12/12)
Garrod 2000 (13/12)
Emtner 2003 (14/15)
Rooyackers 1997 (12/12)
Garrod 2000 (13/12)
Emtner 2003 (14/15)Page 4 of 11
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during exercise on exercise duration and intensity. They
found a small, but statistically not significant increase in
exercise duration and intensity for patients exercising with
ventilation and Heliox. Patient satisfaction for overall
condition, exercise capability and breathing ability meas-
ured with global ratings of change did not differ signifi-
cantly between groups (exact data not available). In this
trial, 73.3% of patients with ventilation, 90.9% of patients
with Heliox and 84.6% of patients without a supplement
completed the trial.
Nutritional supplements
We identified two RCTs that assess the additional benefit
of nutritional supplements during respiratory rehabilita-
tion (table 2, see Additional file 2)[34,35]. Steiner[35] did
Effect of supplemental oxygen on exercise capacityFigure 3
Effect of supplemental oxygen on exercise capacity. The forest plot shows the results from five trials comparing respi-
ratory rehabilitation with and without oxygen. Walking tests, incremental and constant work rate exercise tests were used to 
assess the additional effect of supplemental oxygen during exercise. The x-axis represents the difference in change scores 
between study groups with negative values favoring exercise on room air and positive values favoring exercise with supplemen-
tal oxygen. A difference of 0 means that both study groups changed to the same amount. Boxes with 95% confidence intervals 
represent point estimates for the difference between the walking distance and maximum exercise capacity change scores (from 
baseline to follow-up) of the study groups. Dotted lines represent the minimal important difference of the six-minute walking 
distance (53 meters). On the right of the forest plot, point estimates for differences between groups and 95% confidence inter-
vals are shown.
-30 -25 -20 -15 -10 -5 0 5 10 15 20
Difference (Watt) between maximum 
exercise capacity change scores
Favors room air Favors oxygen
-10 (-26 to 6)Rooyackers 1997 (12/12)
-13.6 (not available)Fichter 1999 (5/5)
3 (-5 to 11)Emtner 2003 (14/15)
Difference (meters) between 
walking distance change scores
Favors room air Favors oxygen
-120 -100 -80 -60 -40 -20 0 20 40 60
Study (n oxygen/room air) Differences (95% CI)
Rooyackers 1997 (12/12) -37 (-99 to 25)
Garrod 2000 (13/12) -24 (-71 to 24)
Wadell 2001 (10/10) -21 (-48 to 6)
Exercise test
Walking test
Incremental 
exercise test
Constant work rate 
test
-4 -2 0 2 4 6 8 10
Favors room air Difference (minutes) between 
exercise duration change scores
Favors oxygen
2.2 (-3.2 to 7.6)
3.9 (-0.6 to 8.4)Emtner 2003 (14/15)
Rooyackers 1997 (12/12)Page 5 of 11
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exercise capacity (table 5, see Additional file 5). In a sub-
group of patients with a BMI>19 kg/m2 (22 in group with
supplement and 30 in group with placebo) the difference
between groups was 27 meters (95% CI 1–53) in the
incremental and 121 seconds (95% CI -44–286) in the
endurance shuttle walk test. Patients with the carbohy-
drate-rich diet increased their body weight compared to
the placebo group by 1.23 kg (95% CI 0.42–2.05), which
occurred mainly because of an increase of the fat mass
(difference between groups 1.46 kg, 95% CI 0.65–2.27).
There was a dropout rate of 40% in the group with and of
16% in the group without carbohydrate-rich diet.
Another RCT[34] found not significant differences
between patients supplemented with an additional fat-
rich diet, but did not report the results in detail and could
not provide these data for our review. Compared to pla-
cebo, non-depleted patients increased their body weight
by 1.5 kg (95% CI 0.4–2.6) when receiving a fat-rich diet
and by 1.6 kg (95% CI 0.39–2.81) when receiving a fat-
rich diet plus anabolic steroids.
Anabolic steroids
Creutzberg[36] (table 2, see Additional file 2) found that
only patients receiving nandrolone improved their HRQL,
whereas patients following the respiratory rehabilitation
program without nandrolone did not change. This trend
was consistent for all domains of the St. George
Respiratory Questionnaire, but only statistically signifi-
cant for the symptom domain (table 5, see Additional file
5). For the subgroup of patients receiving maintenance
treatment with oral glucocorticosteroids, patients with
nandrolone improved their maximum exercise capacity
significantly more. Isometric leg strength and isokinetic
legwork improved in both groups, but did not differ sig-
nificantly between groups. There was a trend in erythropo-
etic parameters towards an increase of erythrocyte count,
hematocrit and hemoglobin in patients treated with nan-
drolone compared to those treated with placebo. No
changes in blood pressures and any androgenic effects or
fluid retention were registered in either group.
Casaburi[24] assessed the additional benefit of testoster-
one for male COPD patients with low testosterone levels
who followed a strength exercise program (table 2, see
Additional file 2). The group with testosterone had larger
increases in exercise capacity and muscle strength, but
none of the differences reached statistical significance
(table 5, see Additional file 5). Total lean mass increased
and total fat mass decreased more in patients with supple-
mental testosterone, but differences between groups were
not significantly different (mean difference in changes
between groups in lean mass 3.09 kg, p > 0.05, and total
fat mass -1.28 kg, p > 0.05). Casaburi found, like Creutz-
berg[36], differences in hemoglobin changes between
groups (mean difference in hemoglobin change between
the testosterone and placebo group 1.4 g/dL, p < 0.05).
They observed neither adverse events nor any differences
in most safety measures between groups (prostate specific
antigen, liver enzymes, alkaline phosphates, cholesterol
and high-density lipoprotein cholesterol) between
groups. Serum creatinine levels, however, increased in the
testosterone group by 0.12 mg/dL and decreased in the
placebo group by 0.05 mg/dL (difference between groups
0.17 mg/dL, p < 0.05).
Tiotropium, Creatine, Coenzyme Q10, and growth 
hormone
Casaburi[37] assessed the additional benefit of tiotro-
pium in 47 patients and found a significantly increased
exercise endurance time compared to patients who
received placebo (n = 44, tables 2 and 5, see Additional
files 2 and 5). Further results were not available. Four
small RCTs evaluated the additional benefit of creat-
ine[38], coenzyme Q10[39] and growth hormone[40,41]
during respiratory rehabilitation, but did not find any
additional benefit on respiratory or peripheral muscle
function or HRQL (tables 2 and 5, see Additional files 2
and 5). Casaburi et al[41] reported that no adverse effects
of growth hormone occurred.
Discussion
There are three main results from this systematic review.
First, evidence suggests that supplemental oxygen during
physical exercise does not provide a clinically relevant
benefit. Second, the evidence for any other supplemental
intervention is not strong enough to recommend or dis-
courage their use in clinical practice and third, there were
major methodological limitations in most trials that may
explain some of the inconclusive findings. We discuss
each of these results in turn.
Cotes[42] reported in 1956 that oxygen increased exercise
performance in patients with COPD. Since then, many
investigators assessed the short-term effect of increased
oxygen availability during exercise[15]. Some investiga-
tors argue that patients tolerate higher exercise intensities
or longer exercise time with supplemental oxygen leading
to larger training effects[43,44]. Others believe that only
without oxygen, an adequate hypoxemic stimulus is pro-
vided for peripheral muscles to improve exercise capacity.
The studies by Emtner[25] and Rooyackers[28] demon-
strated that patients indeed tolerate higher exercise inten-
sities if supplemented by oxygen. Mean differences on the
CRQ domain scores, however, showed a slight but clini-
cally not meaningful trend towards a benefit with oxygen
supplementation (figure 2). The trial by Emtner[25] was
the only one that showed a consistent trend towards aPage 6 of 11
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Across all studies, however, results from exercise testing
were contradicting. Supplemental oxygen did prolong
exercise duration in constant work rate tests, but led to
considerably smaller improvements of functional exercise
capacity (figure 3). It was hypothesized earlier that those
patients with the highest oxygen desaturation during exer-
cise would benefit most from supplemental oxygen[45].
The trials do not provide sufficient evidence for or against
this hypothesis.
There is limited evidence on the safety of oxygen during
exercise and on the safety of exercise without oxygen in
patients with desaturation. Clinicians may have concerns
about training in hypoxemia because of adverse events
and will encourage oxygen supplementation in patients
with desaturation during exercise. In theory, oxygen car-
ries the risk of CO2 retention in COPD patients. The only
trial reporting on CO2 retention[29] did not observe sig-
nificant differences of CO2 levels during exercise tests with
oxygen compared with exercise on room air. However,
exercise tests may have been too short to assess the effect
of CO2 retention. Exercise is a risk indicator for unmask-
ing latent pulmonary hypertension[46], but supplemental
oxygen may reduce this risk by decreasing the sympathetic
tone and the respiratory rate allowing for less end-expira-
tory pressure[47]. Rooyackers[28] did not find any
differences in resting mean pulmonary artery pressure
between patients with and without oxygen. However,
patients stopped exercising when oxygen saturation fell
below 90% so that the risk of the exercise program under
hypoxemic conditions on the development of pulmonary
hypertensions could not be studied.
Several studies found a positive acute effect of oxygen dur-
ing exercise testing on exercise capacity and a number of
physiologic mechanisms for the effects of oxygen have
been proposed [48-50]. However, these results on the
short-term benefit of oxygen during exercise testing seem
not to translate into improvements of clinically relevant
outcomes during exercise programs. Current data do not
suggest benefit from the use of oxygen during exercise to
enhance training effects (figure 3), but show some benefit
in terms of HRQL (figure 2) Given the limited methodo-
logical quality of trials, any conclusions are vague. The
general use of oxygen is only justified, if larger trials of
good quality show its benefit on clinically relevant out-
comes. The mechanisms of the effects of oxygen during
exercise are still insufficiently understood and call for
more basic research[15].
Assisted ventilation also aims at increasing oxygen availa-
bility during exercise, but the trials indicated no addi-
tional benefit. An exception may represent overnight non-
invasive positive pressure ventilation. This treatment may
improve quality of sleep as well as daytime gas levels and
respiratory muscle function thereby providing a better
milieu (pH, PaO2, PaCO2) for peripheral muscle function.
One trial[32] found statistically significant improvements
of functional exercise capacity and also large improve-
ments of HRQL (mean differences between groups 0.45 to
0.85 in CRQ domain scores, table 4, see Additional file 4)
with additional non-invasive positive pressure ventila-
tion. These results support the hypothesis formulated by
authors of a recent meta-analysis showing that nocturnal
non-invasive positive pressure ventilation alone has no
effect on exercise capacity and HRQL, but may be benefi-
cial as an adjunct to respiratory rehabilitation[51]. The
eight trials that assessed various supplemental interven-
tions during rehabilitation produced inconclusive results
that do not allow recommendations for clinical practice
yet.
An important result of this systematic review with impli-
cations for future research is the low methodological qual-
ity and small sample sizes. For example, the majority of
trials did not consider stratification for important prog-
nostic factors such as exercise capacity[52] for randomiza-
tion. In some trials there were baseline imbalances
between groups, for example in terms of exercise capac-
ity[27,28,32,33,40]. The influence of these imbalances on
the results was not investigated in any of the trials.
Concealment of random allocation and blinding of treat-
ment providers or outcome assessors was also not
addressed in most trials.
Sample sizes were small except in three trials[34,35,37].
Pragmatic trials comparing active interventions, as
included in this systematic review, are very useful for clin-
ical practice when clinicians are confronted with the
choice between interventions[53]. However, small sample
sizes are problematic in pragmatic trials for at least two
reasons: First, differences between study groups tend to be
smaller in pragmatic trials than in trials comparing an
active intervention with placebo or a sham intervention.
Figure 4 shows the results and 95% confidence intervals of
a trial comparing respiratory rehabilitation with usual
care and of a trial comparing respiratory rehabilitation
with and without a supplemental intervention with differ-
ent sample sizes. It illustrates the importance of sufficient
sample sizes in pragmatic trials by showing that for prag-
matic RCTs in respiratory rehabilitation, in which widely
established patient-important outcomes such as HRQL
are used, sample sizes of up to 40 per group will produce
imprecise results (large confidence intervals). This impre-
cision hinders interpretation. Another reason for suffi-
cient samples sizes is that in pragmatic trials patient
profiles are usually more variable than in explanatory tri-
als reflecting the wide patient spectrum encountered in
clinical practice[53]. The greater variability in patientPage 7 of 11
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and, on the other side, subgroup analyses will be impor-
tant to assess whether the effects differ between patient
subgroups (effect modification). Subgroup analyses based
on prognostically important patient characteristics will
provide more differentiated evaluations than one mean
for the whole study group, but they require sufficient sam-
ple for well-balanced intervention groups.
We propose that investigators consider the following
aspects in future pragmatic trials on respiratory rehabilita-
tion: First, preliminary sample size considerations should
be based on realistic estimates for expected differences
between groups, which are typically smaller than in trials
without active comparators. To better understand what
these sample sizes mean, 95% confidence intervals
around the predicted point estimate can be calculated as
shown in figure 4. This approach will help to better fore-
see the consequence of different sample sizes on interpre-
tation of the data[54]. Second, COPD patients represent a
heterogeneous group and stratification for prognostically
important variables should be considered to avoid base-
line imbalances that bear on outcomes[55], as seen in
some trials included in this review[27,28,32,33,40].
Third, more attention needs to be paid to general require-
ments for RCTs of high quality like method of
Sample size and interpretation of randomized controlled trials in respiratory rehabilitationFigur  4
Sample size and interpretation of randomized controlled trials in respiratory rehabilitation. Forest plot with sim-
ulated results from two trials with varying sample size, in which the CRQ was used. Boxes with 95% confidence intervals rep-
resent point estimates for the difference between CRQ change scores (from baseline to follow-up) of the study groups. 
Dotted lines represent the minimal important difference of the CRQ (change of 0.5). Trial 1 shows the results from a typical 
explanatory trial comparing respiratory rehabilitation and no respiratory rehabilitation (usual care) with differences in CRQ 
change scores around 0.75[5]. Because of the large effect, trial results are interpretable also with imprecise results. Trial 2 
shows the results from a pragmatic trial assessing the additional effect of a supplemental intervention (for example oxygen dur-
ing exercise). The difference between groups is 0.3 and sample size must be large (80 per group) to produce results that are 
precise enough to allow interpretation.
-.75 -.5 -.25 0 .25 .5 .75 1 1.25
Total sample size 
(per group)
10 (5/5)
20 (10/10)
40 (20/20)
80 (40/40)
320 (160/160)
160 (80/80)
10 (5/5)
20 (10/10)
40 (20/20)
80 (40/40)
320 (160/160)
160 (80/80)
Favors usual care (Trial 1)
Favors usual rehabilitation (Trial 2)
Trial 1: Explanatory trial
Rehabiliation versus no rehabilitation 
(usual care)
Difference between groups : 0.75
Trial 2: Pragmatic trial
Rehabiliation versus rehabilitation plus 
supplemental intervention
Difference between groups: 0.3
Favors rehabilitation (Trial 1)
Favors rehabilitation plus 
supplemental intervention (Trial 2)
Difference between CRQ change scoresPage 8 of 11
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blinding of those who assess treatment effects.
The strengths of our systematic review include the broad
literature search including several databases and extensive
hand searching for trials with direct comparisons of inter-
ventions that are used in clinical practice. In addition, we
contacted authors for additional data and received them
from the majority of investigators. This greatly enhanced
the informativeness of included studies and thereby of
this review. A weakness of this review includes the discus-
sion that is limited to the best-investigated supplements
because of the number of interventions included in this
review. However, the aim of this review was to analyze
current evidence from a meta-epidemiological perspective
not giving to much emphasis to single studies. Some may
criticize that we did not pool the results from trials on
supplemental oxygen during exercise using meta-analysis.
However, desaturation or no desaturation during exercise
was an important inclusion criterion in four of the five tri-
als and investigators wanted to learn about the effect of
supplemental oxygen in these subgroups, in particular.
Therefore, we considered the patient profiles of these trials
to be too different to provide meaningful pooled esti-
mates. Instead, we provided forest plots (figures 2 and 3)
to show the individual studies' point estimates and 95%
confidence intervals for the CRQ domains and the exer-
cise tests to allow comparisons across studies.
In conclusion, data for most supplemental interventions
during respiratory rehabilitation are inconclusive. Oxygen
during exercise does not seem to provide a patient-impor-
tant additional benefit for COPD patients during a respi-
ratory rehabilitation, but methodological shortcomings
of the trials on supplemental oxygen do not allow conclu-
sive answers. Future trials should pay careful attention to
the methodological trial design and to sufficient sample
sizes.
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